10 at 10: These ASX stocks are cruising ahead this morning

Getty Images)
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading.
Stocks highlighted in yellow have made potentially market-moving announcements:
Code | Name | Price | % Chg | Volume |
---|---|---|---|---|
AYM | Australia United Mining Ltd | 0.003 | +200.00% | 10.0k |
CCE | Carnegie Clean Energy Ltd | 0.002 | +100.00% | 500.0k |
ALT | Analytica Ltd | 0.004 | +33.33% | 700.0k |
PPY | Papyrus Australia Ltd | 0.02 | +33.33% | 619.2k |
VAL | Valor Resources Ltd | 0.004 | +33.33% | 300.0k |
DDD | 3D Resources Ltd | 0.002 | +33.33% | 742.0k |
MLS | Metals Australia Ltd | 0.002 | +33.33% | 490.6k |
IMU | Imugene Ltd | 0.03 | +28.85% | 45.6M |
DTM | Dart Mining NL | 0.006 | +20.00% | 100.0k |
EM1 | Emerge Gaming Ltd | 0.02 | +20.00% | 2.5M |
Tech company Papyrus (ASX:PPY), which develops products from the material found in banana trees, jumped sharply at the opening bell after announcing that Sydney-based investment company Union Pacific Equities had agreed to buy 19.9 per cent of PPY’s issued shares.
These 10 stocks are lagging the pack in morning trade:
Code | Name | Price | % Chg | Volume |
---|---|---|---|---|
VIC | Victory Mines Ltd | 0.001 | -33.33% | 3.9M |
FTT | Factor Therapeutics Ltd | 0.002 | -25.00% | 1.2M |
SUD | Suda Pharmaceuticals Ltd | 0.002 | -20.00% | 5.0M |
MHC | Manhattan Corp Ltd | 0.004 | -20.00% | 100.0k |
EVE | EVE Investments Ltd | 0.005 | -16.67% | 3.6M |
AZI | Alta Zinc Ltd | 0.005 | -16.67% | 8.5M |
IGN | Ignite Ltd | 0.03 | -13.33% | 17.5k |
AMD | Arrow Minerals Ltd | 0.007 | -12.50% | 1.0M |
GTR | GTI Resources Ltd | 0.01 | -9.09% | 1.0M |
EXR | Elixir Energy Ltd | 0.04 | -8.51% | 879.1k |
UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.